Radiation recall dermatitis with dabrafenib and trametinib: A case report

doi:10.12998/wjcc.v8.i3.522

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8406)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

385

WORD

190

HTML

3761

Figures (1-3)

641

Sum=4977

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

360

Download

902

Sum=1262

Publishing Process of This Article

Item

Count

Browse

801

Download

1358

Sum=2159

Feb 6, 2020 (publication date) through Jan 1, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 6, 2020; 8(3): 522-526
Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.522

Full Size Figure Download Figure

Figure 1 One month after completion of radiotherapy, discolored and inflamed skin limited to the region previously irradiated was observed while being treated with BRAF and MEK inhibitor combination therapy. A: Front view of right leg-discolored and inflamed skin limited to the region previously irradiated; B: Back view of right leg-discolored and inflamed skin limited to the region previously irradiated; C: Front view of right leg; D: Back view of right leg.

Citation: Yilmaz M, Celik U, Hascicek S. Radiation recall dermatitis with dabrafenib and trametinib: A case report. World J Clin Cases 2020; 8(3): 522-526
URL: https://www.wjgnet.com/2307-8960/full/v8/i3/522.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i3.522